Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Worldwide Offices
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Your Telehealth Doctor Must Be Licensed in the State You're In, Not the State They're In, Promise Analysis Finds


News provided by

Promise

20 Aug, 2026, 18:14 GMT

Share this article

Share toX

Share this article

Share toX

3,633 physician licenses were issued in a single month through the Interstate Medical Licensure Compact — American Medical Association, 2026.

SCOTTSDALE, Ariz., Aug. 20, 2026 /PRNewswire/ -- Promise, a Scottsdale-based telehealth platform offering doctor-guided consultations for peptide therapy, weight management, and hormone care, today released an analysis of how physician licensure works across state lines in telehealth, and why the answer matters more to patients than most realize.

Continue Reading
This image opens in the lightbox
Promise

Drawing on data from the Federation of State Medical Boards (FSMB), the American Medical Association (AMA), and the Center for Connected Health Policy (CCHP), the analysis lays out the governing rule, the compact system built to scale it nationally, and what patients should verify before starting a telehealth visit.

The Interstate Medical Licensure Compact (IMLC), the primary mechanism states use to speed up multi-state physician licensing, issued 3,633 physician licenses in March 2026 alone, up from just three licenses in its first month of operation in April 2017, according to IMLCC data from 2026. It also found that more than 200,000 licenses have been issued through the compact since launch, and the compact now spans 44 states plus D.C. and Guam. The scale of that growth is, in itself, a signal of how much cross-state telehealth demand the licensure system has had to absorb.

The rule that hasn't changed

Under longstanding guidance from the Federation of State Medical Boards, a physician must be licensed, or otherwise appropriately authorized, by the medical board of the state where the patient is physically located at the time telemedicine technologies are used, not the state where the physician's practice is based. That guidance, formalized in FSMB's model telemedicine policy, has anchored state medical board enforcement for years and remains the operative standard in 2026.

In practice, this means a patient logging into a telehealth visit from Arizona needs the assigned physician to hold authorization to practice in Arizona, regardless of where that physician's medical group, headquarters, or primary license happens to be. The rule is easy to overlook because a telehealth visit doesn't feel geographically specific; it's a video call, an intake form, a follow-up message. However, the location of the patient (not the provider) is what determines which state's medical board has jurisdiction over the encounter.

How compact licensure scaled to meet demand

Since the location-of-patient rule effectively requires physicians to hold authorization in every state where they see patients, states built the Interstate Medical Licensure Compact to make that multi-state process faster than applying to each state board individually.

According to an AMA article from 2026, nearly 11,000 physician applications for an IMLCC "Letter of Qualification", the credential that initiates the compact licensing process, were completed between April 2025 and March 2026 alone. The compact's geographic footprint has kept pace with that volume: According to an IMLCC press release from 2026, Alaska became the IMLC's 44th member state, and 46th member-jurisdiction overall, counting D.C. and Guam, on June 26, 2026, per the Interstate Medical Licensure Compact Commission.

The IMLC is not the only mechanism states have built to scale cross-state telehealth access. The Center for Connected Health Policy, from October 2025, tracks 13 distinct interstate licensure compacts relevant to telehealth practice across professions, spanning medicine, nursing, and allied health fields. Separately, 18 states, plus the U.S. Virgin Islands and Puerto Rico, have established a telehealth-specific special registration or licensure process as an alternative route to full in-state licensure, according to CCHP's Fall 2025 State Report on Telehealth Laws and Reimbursement Policies.

Taken together, these mechanisms mean a physician can now be authorized to see a patient in a given state through several different regulatory pathways, not just a traditional single-state license.

Why the patient's location decides the license check

The practical effect of the FSMB's location-of-patient standard is that licensure verification runs in the patient's state, not the provider's headquarters or the platform's state of incorporation. A telehealth company's physician network can span dozens of states, but what governs any single consultation is where the patient is physically located when that consultation happens.

That distinction reframes what patients should actually be researching. Confirming where a telehealth company is based, or how large its physician network is, doesn't answer the licensure question. The relevant fact is narrower: whether the specific physician assigned to a given patient is licensed, or authorized through a compact or special-registration pathway, in that patient's own state at the time of the visit. Since compact and special-registration pathways have expanded so quickly, from three IMLC licenses issued in an entire month in 2017 to 3,633 in one month in 2026, a "not licensed here" answer is now the exception in most compact-member states rather than the default barrier it once was.

However, coverage still isn't universal; with 44 states plus D.C. and Guam participating in the IMLC as of Alaska's June 2026 addition, a handful of states remain outside the compact. This means a physician's ability to rely on expedited compact licensure still depends on exactly which state the patient is in, as opposed to a traditional single-state license or one of the 18 states' telehealth-specific registration alternatives tracked by CCHP. That state-by-state variation is precisely why the verification question belongs to the patient's location and can't be answered in the abstract, even as the overall system has scaled to make cross-state authorization faster to obtain.

Given how much licensure infrastructure now sits behind a routine telehealth visit, the analysis recommends that patients treat licensure verification as a standard part of starting care, not an afterthought. Three checks are most relevant: whether the platform's consultation model requires a licensed physician to review a patient's case before any prescription decision is made. According to the Federation of State Medical Boards (FSMB)'s policy statement in April 2022, the assigned physician is licensed or otherwise authorized to practice in the patient's own state, and the platform can explain, in plain terms, how it satisfies state-by-state licensure requirements rather than treating the question as a formality buried in terms of service.

Consultation-first models are built around this structure by design. On Promise, every treatment begins with an online consultation, and a licensed physician determines whether a prescription is appropriate for that specific patient; nothing is issued without provider review. Patients can start a consultation for programs including sermorelin, semaglutide, and tirzepatide; from there, it is the reviewing physician, working within the licensure framework described above, who determines next steps for that patient's care.

Methodology

Promise synthesized publicly available data from the Federation of State Medical Boards' 2022 model telemedicine policy ("The Appropriate Use of Telemedicine Technologies in the Practice of Medicine"), American Medical Association reporting on Interstate Medical Licensure Compact Commission data published in 2026, and the Center for Connected Health Policy's Fall 2025 State Telehealth Laws and Reimbursement Policies Report. No proprietary survey was conducted. All figures are drawn from named third-party sources and reflect information publicly available as of July 2026.

Frequently Asked Questions

Does my telehealth doctor need to be licensed in the state I'm physically in, or the state they're in?

A telehealth physician must be licensed, or otherwise appropriately authorized, in the state where the patient is physically located at the time of the visit, not the state where the physician is based. This standard comes from the Federation of State Medical Boards' model telemedicine policy and governs how state medical boards oversee telehealth encounters.

Why does my location matter more than the doctor's?

A patient's location determines which state medical board has jurisdiction over a given telehealth encounter, since licensure and oversight are tied to where care is delivered, not where the physician's practice is headquartered. A single physician network can include doctors authorized across dozens of states, but each individual consultation is governed by the state the patient is in at that moment.

What should I actually check before a telehealth visit?

Patients starting telehealth care should confirm that a licensed physician reviews their case before any prescription decision is made, that the assigned physician is authorized to practice in the patient's own state, and that the platform can clearly describe how it handles state-by-state licensure rather than leaving the question unaddressed.

What happens if a telehealth doctor isn't licensed in a patient's state?

A telehealth physician who lacks licensure or authorization in the patient's state is generally not permitted to diagnose, treat, or prescribe for that patient under that state's medical board rules, regardless of the physician's standing elsewhere. Reputable telehealth platforms address this by matching patients to physicians already licensed, or authorized through a compact or special-registration pathway, in the patient's own state before a consultation is scheduled, which is why confirming that match in advance, rather than assuming it, is part of informed telehealth use.

Does a compact license change how care is delivered during a telehealth visit?

Compact licensure changes how quickly a physician becomes authorized to practice in a given state, not how care is delivered once that authorization is in place. A physician who obtains a license through the Interstate Medical Licensure Compact is held to the same standards and falls under the same state medical board jurisdiction as a physician who obtained a traditional single-state license. For patients, the practical difference is upstream, faster physician authorization in more states, rather than in the structure of the consultation itself.

About Promise

Promise is a Scottsdale, Arizona-based telehealth platform, founded in 2026, offering doctor-guided care for peptide therapy, weight management, and hormone health. Every Promise treatment starts with an online consultation with a licensed physician, who determines whether a prescription is appropriate; nothing is sold without provider review. Current programs include sermorelin, semaglutide, and tirzepatide. More information is available at mypromise.com.

Media Contact

Source: Promise

Contact: Max Power

Email: max@mypromise.com

Location: Scottsdale, AZ

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content

About

  • About PR Newswire
  • About Cision
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • PR Newswire Amplify™
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2026 PR Newswire Europe Limited. All Rights Reserved. A Cision company.